Description
Release form
Suspension for intramuscular administration
Packing
10 ampoules.
Pharmacological action of
Enetsovir causes the formation of specific immunity to tick-borne encephalitis virus in people from a strain of the virus isolated in Russia, provides protection against all known subtypes of tick-borne encephalitis virus. Causes in people the formation of specific immunity against tick-borne encephalitis virus provides protection against virus strains circulating in both Asia and Europe.
Indications
Used for the active prevention of tick-borne encephalitis in people from 3 years of age.
The contingents to be vaccinated: the population living in tick-borne encephalitis endemic areas
persons who arrived in endemic areas and perform agricultural, irrigation and drainage, construction, procurement, fishing, geological, survey, expeditionary, deratization and disinsection works, and the movement of soil, for logging, clearing and improvement of the forest, recreation and recreation areas of the population
persons, donors working with live cultures of tick-borne encephalitis causative agent
whose blood is used to obtain specific immunoglobulin.
Contraindications
Acute febrile illness of any etiology and exacerbation of chronic infectious diseases. vaccinations are carried out 1 month after recovery. To persons after viral hepatitis and meningococcal infection, vaccination is carried out no earlier than 6 months after recovery.
Severe allergic reactions in the history of food (especially chicken protein), drugs, bronchial asthma, systemic diseases of the connective tissue.
Violent reaction (fever above 40 ° C, edema, hyperemia more than 8 cm in diameter at the injection site) or complication of the previous dose of the vaccine.
Tuberculosis and rheumatism.
Epilepsy with frequent seizures.
Chronic diseases of the liver and kidneys during the exacerbation period, cardiovascular insufficiency of 2-3 degrees, myocardial infarction, stroke.
Diabetes, thyrotoxicosis and other pronounced endocrine disorders.
Malignant neoplasms, blood diseases.
Pregnancy – vaccinations are acceptable 2 weeks after birth.
contains in one dose (0.5 ml): chicken embryo protein no more than 0.5 μg, human albumin donor no more than 250 μg, aluminum hydroxide gel from 0.30 to 0.50 mg. The vaccine does not contain antibiotics, formaldehyde and preservatives.
Dosage and administration
The initial course of vaccination consists of two intramuscular injections of 0.5 ml of the vaccine with an interval of 5-7 months.
For emergency prophylaxis, double vaccination with a dose of 0.5 ml with an interval of 1 to 2 months is recommended
Revaccination is carried out once in a dose of 0.5 ml 1 year after completion of the initial course of vaccination.
Subsequent long-term revaccinations are carried out once every 3 years. In foci with a high risk of infection, a whole healthy population with the ability to contact with ticks is vaccinated.
The vaccine is administered intramuscularly in the deltoid muscle of the shoulder.
Side effects of
After administration of the vaccine, local and general reactions may develop in some cases. Local reactions are expressed in redness, swelling, pain at the injection site, a slight increase in regional lymph nodes is possible. The duration of the reactions does not exceed 3-5 days.
General reactions can develop in the first two days and are expressed in a rise in temperature from 37.1 ° C to 38.0 ° C in 15-19% of vaccinees, headache, malaise, pain in muscles and joints. Their duration does not exceed 3 days.
In rare cases, vaccinations can be accompanied by the development of allergic reactions, in connection with which the vaccinated should be under medical supervision for 30 minutes after vaccination.
Storage conditions
Store at a temperature of 2 to 8 ° C. Do not freeze!
Active ingredient
Vaccine for the prevention of tick-borne encephalitis
lekarstvennaja form
Solution for
Microgen NPO, Russia
